A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy
Clinical trial NCT04737837 · UNKNOWN
Trial details
- NCT number
- NCT04737837
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-31
- Primary completion
- 2021-11-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.